OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
64 hedge funds and large institutions have $27.5M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
72% less call options, than puts
Call options by funds: $327K | Put options by funds: $1.15M
Holders
64
Holding in Top 10
–
Calls
$327K
Puts
$1.15M
Top Buyers
| 1 | +$1.38M | |
| 2 | +$1.03M | |
| 3 | +$699K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$640K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$233K |
Top Sellers
| 1 | -$8.18M | |
| 2 | -$1.81M | |
| 3 | -$168K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$127K |
| 5 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$126K |